Tissue plasminogen activator in central nervous system physiology and pathology

Although conventionally associated with fibrin clot degradation, recent work has uncovered new functions for the tissue plasminogen activator (tPA)/plasminogen cascade in central nervous system physiology and pathology. This extracellular proteolytic cascade has been shown to have roles in learning and memory, stress, neuronal degeneration, addiction and Alzheimer's disease. The current review considers the different ways tPA functions in the brain.

[1]  Sidney Strickland,et al.  Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Nobuko Mataga,et al.  Experience-Dependent Pruning of Dendritic Spines in Visual Cortex by Tissue Plasminogen Activator , 2004, Neuron.

[3]  Mriganka Sur,et al.  Dendritic Spine Dynamics Are Regulated by Monocular Deprivation and Extracellular Matrix Degradation , 2004, Neuron.

[4]  Karim Benchenane,et al.  Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling* , 2004, Journal of Biological Chemistry.

[5]  D. Lawrence,et al.  New Functions for an Old Enzyme: Nonhemostatic Roles for Tissue-Type Plasminogen Activator in the Central Nervous System , 2004, Experimental biology and medicine.

[6]  C. Pavlides,et al.  Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  José A Fernández,et al.  Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C , 2004, Nature Medicine.

[8]  D. Wells,et al.  Rapid, Activity-Induced Increase in Tissue Plasminogen Activator Is Mediated by Metabotropic Glutamate Receptor-Dependent mRNA Translation , 2004, The Journal of Neuroscience.

[9]  Petti T. Pang,et al.  Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity , 2004, Science.

[10]  Joseph E LeDoux,et al.  Molecular Mechanisms Underlying Emotional Learning and Memory in the Lateral Amygdala , 2004, Neuron.

[11]  D. Lawrence,et al.  Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system , 2017 .

[12]  T. Nabeshima,et al.  The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Delacourte,et al.  Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains , 2003, EMBO reports.

[14]  D. Selkoe,et al.  Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.

[15]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[16]  J. Melchor,et al.  The Tissue Plasminogen Activator-Plasminogen Proteolytic Cascade Accelerates Amyloid-β (Aβ) Degradation and Inhibits Aβ-Induced Neurodegeneration , 2003, The Journal of Neuroscience.

[17]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[18]  Nicholas W Seeds,et al.  Absence of Tissue Plasminogen Activator Gene or Activity Impairs Mouse Cerebellar Motor Learning , 2003, The Journal of Neuroscience.

[19]  A. Akhmedov,et al.  Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin , 2003, Molecular and Cellular Neuroscience.

[20]  S. Strickland,et al.  The hippocampal laminin matrix is dynamic and critical for neuronal survival. , 2003, Molecular biology of the cell.

[21]  J. Vassalli,et al.  Emotions are building up in the field of extracellular proteolysis. , 2003, Trends in molecular medicine.

[22]  S. Strickland,et al.  Tissue plasminogen activator and NMDA receptor cleavage , 2003, Nature Medicine.

[23]  B. McEwen,et al.  Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior , 2003, Nature Neuroscience.

[24]  S. Strickland,et al.  Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury , 2003, Neuroscience.

[25]  J. Melchor,et al.  The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  N. Nagai,et al.  Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice , 2002, Neuroscience.

[27]  T. Coleman,et al.  Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. , 2002, The Journal of clinical investigation.

[28]  T. Hensch,et al.  Permissive proteolytic activity for visual cortical plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Siao,et al.  Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II , 2002, The Journal of Neuroscience.

[30]  Sidney Strickland,et al.  Localization and Regulation of the Tissue Plasminogen Activator–Plasmin System in the Hippocampus , 2002, The Journal of Neuroscience.

[31]  P. Sonderegger,et al.  Neuroserpin, a Neuroprotective Factor in Focal Ischemic Stroke , 2001, Molecular and Cellular Neuroscience.

[32]  D. Collen.  Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. , 2001, Hematology. American Society of Hematology. Education Program.

[33]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.

[34]  A. Delacourte,et al.  Brain plasmin enhances APP α‐cleavage and Aβ degradation and is reduced in Alzheimer's disease brains , 2000 .

[35]  S. Estus,et al.  Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and Deposition , 2000, Journal of neurochemistry.

[36]  T. Coleman,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Neuroserpin reduces cerebral infarct volume and protects neurons from , 2022 .

[37]  S. Scheff,et al.  The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates , 2000, The Journal of Neuroscience.

[38]  N. Nishiyama,et al.  Laminin Degradation by Plasmin Regulates Long-Term Potentiation , 2000, The Journal of Neuroscience.

[39]  D. Holtzman,et al.  Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation , 2000, The Journal of Neuroscience.

[40]  S. Scheff,et al.  The Plasmin System Is Induced by and Degrades Amyloid-b Aggregates , 2000 .

[41]  M. Basham,et al.  Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Nicoll,et al.  Long-term potentiation--a decade of progress? , 1999, Science.

[43]  W. V. Van Nostrand,et al.  Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. , 1999, Biochemistry.

[44]  D. Collen.  The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.

[45]  Dominique Muller,et al.  Enhanced hippocampal long‐term potentiation and learning by increased neuronal expression of tissue‐type plasminogen activator in transgenic mice , 1999, The EMBO journal.

[46]  P. Carmeliet,et al.  Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. , 1999, Circulation.

[47]  Mary Chen,et al.  Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway , 1998, Neuron.

[48]  David P. Wolfer,et al.  Spatial Memory and Learning in Transgenic Mice: Fact or Artifact? , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[49]  C. Müller,et al.  Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex , 1998, Nature Neuroscience.

[50]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[51]  S. Strickland,et al.  Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin , 1997, Cell.

[52]  S. Tsirka,et al.  Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Miskin,et al.  mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. , 1997, Brain research. Molecular brain research.

[54]  S. Mahata,et al.  Tissue Plasminogen Activator (t-PA) Is Targeted to the Regulated Secretory Pathway , 1997, The Journal of Biological Chemistry.

[55]  S. Tsirka,et al.  Neuronal cell death and tPA , 1996, Nature.

[56]  Y. Yoshimura,et al.  Enhancement of mRNA expression of tissue-type plasminogen activator by l-threo-3,4-dihydroxyphenylserine in association with ocular dominance plasticity , 1996, Neuroscience Letters.

[57]  S. Strickland,et al.  Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  L. Parnetti,et al.  Hemostasis Abnormalities in Patients with Vascular Dementia and Alzheimer’s Disease , 1996, Thrombosis and Haemostasis.

[59]  P. Bickford,et al.  Tissue Plasminogen Activator Induction in Purkinje Neurons After Cerebellar Motor Learning , 1995, Science.

[60]  Sidney Strickland,et al.  Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator , 1995, Nature.

[61]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. , 1994, The Journal of biological chemistry.

[62]  S. Vandenberg,et al.  Plasminogen activator inhibitor‐1 in the cerebrospinal fluid as an index of neurological disease , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[63]  P. Carmeliet,et al.  Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.

[64]  Eric R. Kandel,et al.  Tissue-plasminogen activator is induced as an immediate–early gene during seizure, kindling and long-term potentiation , 1993, Nature.

[65]  R. Pittman.  Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons. , 1985, Developmental biology.